JP2004536617A - 核酸増幅方法 - Google Patents
核酸増幅方法 Download PDFInfo
- Publication number
- JP2004536617A JP2004536617A JP2003517293A JP2003517293A JP2004536617A JP 2004536617 A JP2004536617 A JP 2004536617A JP 2003517293 A JP2003517293 A JP 2003517293A JP 2003517293 A JP2003517293 A JP 2003517293A JP 2004536617 A JP2004536617 A JP 2004536617A
- Authority
- JP
- Japan
- Prior art keywords
- probe
- amplification product
- product
- amplification
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000003199 nucleic acid amplification method Methods 0.000 title claims abstract description 120
- 239000000523 sample Substances 0.000 claims abstract description 186
- 238000000034 method Methods 0.000 claims abstract description 85
- 230000003321 amplification Effects 0.000 claims description 116
- 108091034117 Oligonucleotide Proteins 0.000 claims description 86
- 238000006243 chemical reaction Methods 0.000 claims description 50
- 150000007523 nucleic acids Chemical class 0.000 claims description 39
- 108091008146 restriction endonucleases Proteins 0.000 claims description 34
- 108020004707 nucleic acids Proteins 0.000 claims description 33
- 102000039446 nucleic acids Human genes 0.000 claims description 33
- 239000000178 monomer Substances 0.000 claims description 31
- 238000009396 hybridization Methods 0.000 claims description 25
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 21
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 21
- 230000000295 complement effect Effects 0.000 claims description 20
- 102000004190 Enzymes Human genes 0.000 claims description 19
- 108090000790 Enzymes Proteins 0.000 claims description 19
- 238000001514 detection method Methods 0.000 claims description 16
- 230000015556 catabolic process Effects 0.000 claims description 13
- 238000006731 degradation reaction Methods 0.000 claims description 13
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 12
- 238000013461 design Methods 0.000 claims description 11
- 230000001419 dependent effect Effects 0.000 claims description 10
- 230000008569 process Effects 0.000 claims description 9
- 108020004414 DNA Proteins 0.000 claims description 8
- 238000010494 dissociation reaction Methods 0.000 claims description 8
- 230000005593 dissociations Effects 0.000 claims description 8
- 239000002299 complementary DNA Substances 0.000 claims description 7
- 239000000758 substrate Substances 0.000 claims description 7
- 108010042407 Endonucleases Proteins 0.000 claims description 6
- 238000002866 fluorescence resonance energy transfer Methods 0.000 claims description 6
- 230000000415 inactivating effect Effects 0.000 claims description 6
- 239000003446 ligand Substances 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 6
- 108091028732 Concatemer Proteins 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 238000010791 quenching Methods 0.000 claims description 5
- 230000000171 quenching effect Effects 0.000 claims description 5
- 108060002716 Exonuclease Proteins 0.000 claims description 4
- 102000013165 exonuclease Human genes 0.000 claims description 4
- 230000003993 interaction Effects 0.000 claims description 4
- 230000010076 replication Effects 0.000 claims description 4
- 102100031780 Endonuclease Human genes 0.000 claims description 3
- 102100034343 Integrase Human genes 0.000 claims description 3
- 230000008859 change Effects 0.000 claims description 3
- 230000002794 monomerizing effect Effects 0.000 claims description 3
- 101710203526 Integrase Proteins 0.000 claims description 2
- 230000011664 signaling Effects 0.000 claims description 2
- 238000012546 transfer Methods 0.000 claims description 2
- 230000008684 selective degradation Effects 0.000 claims 2
- 239000000047 product Substances 0.000 description 127
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 27
- 238000007363 ring formation reaction Methods 0.000 description 21
- 239000012634 fragment Substances 0.000 description 19
- 238000003776 cleavage reaction Methods 0.000 description 15
- 230000007017 scission Effects 0.000 description 15
- 102000012410 DNA Ligases Human genes 0.000 description 13
- 108010061982 DNA Ligases Proteins 0.000 description 13
- 238000003752 polymerase chain reaction Methods 0.000 description 12
- 230000008030 elimination Effects 0.000 description 11
- 238000003379 elimination reaction Methods 0.000 description 11
- 238000006116 polymerization reaction Methods 0.000 description 11
- 239000003086 colorant Substances 0.000 description 10
- 239000000872 buffer Substances 0.000 description 9
- 230000029087 digestion Effects 0.000 description 9
- 230000002779 inactivation Effects 0.000 description 9
- 238000002493 microarray Methods 0.000 description 8
- 238000012544 monitoring process Methods 0.000 description 8
- 102000003960 Ligases Human genes 0.000 description 7
- 108090000364 Ligases Proteins 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- 238000002372 labelling Methods 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 238000005096 rolling process Methods 0.000 description 6
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 5
- 238000009825 accumulation Methods 0.000 description 5
- 239000000975 dye Substances 0.000 description 5
- 230000014509 gene expression Effects 0.000 description 5
- 239000002751 oligonucleotide probe Substances 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- 102000053602 DNA Human genes 0.000 description 4
- 101710163270 Nuclease Proteins 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000036425 denaturation Effects 0.000 description 4
- 238000004925 denaturation Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 238000011002 quantification Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- 102000004533 Endonucleases Human genes 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000010195 expression analysis Methods 0.000 description 3
- 238000007429 general method Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 108020004638 Circular DNA Proteins 0.000 description 2
- 238000000018 DNA microarray Methods 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 102000018120 Recombinases Human genes 0.000 description 2
- 108010091086 Recombinases Proteins 0.000 description 2
- 238000012300 Sequence Analysis Methods 0.000 description 2
- 108010064978 Type II Site-Specific Deoxyribonucleases Proteins 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
- 230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 238000007834 ligase chain reaction Methods 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000001226 triphosphate Substances 0.000 description 2
- 235000011178 triphosphate Nutrition 0.000 description 2
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 2
- JVKRKMWZYMKVTQ-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]pyrazol-1-yl]-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C=NN(C=1)CC(=O)NC1=CC2=C(NC(O2)=O)C=C1 JVKRKMWZYMKVTQ-UHFFFAOYSA-N 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000004150 Flap endonucleases Human genes 0.000 description 1
- 108090000652 Flap endonucleases Proteins 0.000 description 1
- 108091092584 GDNA Proteins 0.000 description 1
- 235000003332 Ilex aquifolium Nutrition 0.000 description 1
- 235000002296 Ilex sandwicensis Nutrition 0.000 description 1
- 235000002294 Ilex volkensiana Nutrition 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
- 108010020713 Tth polymerase Proteins 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 102000023732 binding proteins Human genes 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- OWMVSZAMULFTJU-UHFFFAOYSA-N bis-tris Chemical compound OCCN(CCO)C(CO)(CO)CO OWMVSZAMULFTJU-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000010224 classification analysis Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000037029 cross reaction Effects 0.000 description 1
- 238000013211 curve analysis Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000001036 exonucleolytic effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- -1 for example Proteins 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000007116 intermolecular coupling reaction Methods 0.000 description 1
- 238000003402 intramolecular cyclocondensation reaction Methods 0.000 description 1
- UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001915 proofreading effect Effects 0.000 description 1
- UMSVPCYSAUKCAZ-UHFFFAOYSA-N propane;hydrochloride Chemical compound Cl.CCC UMSVPCYSAUKCAZ-UHFFFAOYSA-N 0.000 description 1
- 230000004850 protein–protein interaction Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 108010068698 spleen exonuclease Proteins 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- PIEPQKCYPFFYMG-UHFFFAOYSA-N tris acetate Chemical compound CC(O)=O.OCC(N)(CO)CO PIEPQKCYPFFYMG-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6848—Nucleic acid amplification reactions characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0118959A GB2378245A (en) | 2001-08-03 | 2001-08-03 | Nucleic acid amplification method |
| PCT/SE2002/001378 WO2003012119A2 (en) | 2001-08-03 | 2002-07-12 | Nucleic acid amplification method |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008316989A Division JP4559517B2 (ja) | 2001-08-03 | 2008-12-12 | 核酸増幅方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2004536617A true JP2004536617A (ja) | 2004-12-09 |
Family
ID=9919749
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003517293A Pending JP2004536617A (ja) | 2001-08-03 | 2002-07-12 | 核酸増幅方法 |
| JP2008316989A Expired - Lifetime JP4559517B2 (ja) | 2001-08-03 | 2008-12-12 | 核酸増幅方法 |
| JP2009230088A Expired - Lifetime JP4675424B2 (ja) | 2001-08-03 | 2009-10-02 | 核酸増幅方法 |
| JP2010125694A Expired - Lifetime JP5313204B2 (ja) | 2001-08-03 | 2010-06-01 | 核酸増幅方法 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008316989A Expired - Lifetime JP4559517B2 (ja) | 2001-08-03 | 2008-12-12 | 核酸増幅方法 |
| JP2009230088A Expired - Lifetime JP4675424B2 (ja) | 2001-08-03 | 2009-10-02 | 核酸増幅方法 |
| JP2010125694A Expired - Lifetime JP5313204B2 (ja) | 2001-08-03 | 2010-06-01 | 核酸増幅方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US7320860B2 (cg-RX-API-DMAC7.html) |
| EP (4) | EP1423532B1 (cg-RX-API-DMAC7.html) |
| JP (4) | JP2004536617A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2002314693A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2455803A1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB2378245A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2003012119A2 (cg-RX-API-DMAC7.html) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008522628A (ja) * | 2004-12-11 | 2008-07-03 | サイトジェニックス， インコーポレイテッド | 高品質核酸のセルフリー生合成及びその使用 |
| JP2009077735A (ja) * | 2001-08-03 | 2009-04-16 | Biocyclica Ab | 核酸増幅方法 |
| JP2011505161A (ja) * | 2007-12-04 | 2011-02-24 | ピエール、ファーブル、メディカマン | 抗体ライブラリーを作製およびスクリーニングするための新規な方法 |
Families Citing this family (116)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0304371D0 (en) * | 2003-02-26 | 2003-04-02 | Solexa Ltd | DNA Sequence analysis |
| US7385043B1 (en) * | 2003-04-30 | 2008-06-10 | The Public Health Research Institute Of The City Of New York, Inc. | Homogeneous multiplex screening assays and kits |
| SE0401270D0 (sv) | 2004-05-18 | 2004-05-18 | Fredrik Dahl | Method for amplifying specific nucleic acids in parallel |
| WO2005113804A1 (en) * | 2004-05-20 | 2005-12-01 | Trillion Genomics Limited | Use of mass labelled probes to detect target nucleic acids using mass spectrometry |
| EP1784754A4 (en) * | 2004-08-13 | 2009-05-27 | Harvard College | OPTI-NANOPORE DNA READING PLATFORM WITH ULTRAHOLE THROUGHPUT |
| JP5103398B2 (ja) * | 2005-06-06 | 2012-12-19 | ４５４ ライフ サイエンシーズ コーポレイション | 両末端配列決定（ｐａｉｒｅｄｅｎｄｓｅｑｕｅｎｃｉｎｇ） |
| EP1910537A1 (en) | 2005-06-06 | 2008-04-16 | 454 Life Sciences Corporation | Paired end sequencing |
| US20090264299A1 (en) | 2006-02-24 | 2009-10-22 | Complete Genomics, Inc. | High throughput genome sequencing on DNA arrays |
| EP2620510B2 (en) | 2005-06-15 | 2020-02-19 | Complete Genomics Inc. | Single molecule arrays for genetic and chemical analysis |
| US8137936B2 (en) * | 2005-11-29 | 2012-03-20 | Macevicz Stephen C | Selected amplification of polynucleotides |
| US8460879B2 (en) | 2006-02-21 | 2013-06-11 | The Trustees Of Tufts College | Methods and arrays for target analyte detection and determination of target analyte concentration in solution |
| WO2008070352A2 (en) | 2006-10-27 | 2008-06-12 | Complete Genomics, Inc. | Efficient arrays of amplified polynucleotides |
| US20090075343A1 (en) | 2006-11-09 | 2009-03-19 | Complete Genomics, Inc. | Selection of dna adaptor orientation by nicking |
| US7862999B2 (en) * | 2007-01-17 | 2011-01-04 | Affymetrix, Inc. | Multiplex targeted amplification using flap nuclease |
| US20100047792A1 (en) * | 2007-04-10 | 2010-02-25 | Szendroe Istvan | Label-free optical detection method |
| US20080293589A1 (en) * | 2007-05-24 | 2008-11-27 | Affymetrix, Inc. | Multiplex locus specific amplification |
| KR20100089060A (ko) * | 2007-10-04 | 2010-08-11 | 할싸이언 몰레큘러 | 전자 현미경으로 핵산 중합체를 시퀀싱하는 방법 |
| US8415099B2 (en) | 2007-11-05 | 2013-04-09 | Complete Genomics, Inc. | Efficient base determination in sequencing reactions |
| WO2009073629A2 (en) | 2007-11-29 | 2009-06-11 | Complete Genomics, Inc. | Efficient shotgun sequencing methods |
| US8592150B2 (en) | 2007-12-05 | 2013-11-26 | Complete Genomics, Inc. | Methods and compositions for long fragment read sequencing |
| WO2009097368A2 (en) | 2008-01-28 | 2009-08-06 | Complete Genomics, Inc. | Methods and compositions for efficient base calling in sequencing reactions |
| US20090233809A1 (en) * | 2008-03-04 | 2009-09-17 | Affymetrix, Inc. | Resequencing methods for identification of sequence variants |
| WO2010065568A2 (en) | 2008-12-01 | 2010-06-10 | Laboratory Corporation Of America Holdings | METHODS AND ASSAYS FOR MEASURING p95 AND/OR p95 IN A SAMPLE AND ANTIBODIES SPECIFIC FOR p95 |
| BRPI1007321A2 (pt) | 2009-01-15 | 2018-07-10 | Laboratory Corp America Holdings | métodos para medir e/ou quantificar a presença e/ou quantidade de her-3 ou her-3 em um complexo em uma amostra de um paciente, e para determinar se um indivíduo com um câncer é provável de responder ao tratamento com uma terapia alvejada, e, anticorpo. |
| SG172984A1 (en) * | 2009-01-15 | 2011-08-29 | Lab Corp America Holdings | Methods of determining patient response by measurement of her-2 expression |
| WO2010126614A2 (en) | 2009-04-30 | 2010-11-04 | Good Start Genetics, Inc. | Methods and compositions for evaluating genetic markers |
| US12129514B2 (en) | 2009-04-30 | 2024-10-29 | Molecular Loop Biosolutions, Llc | Methods and compositions for evaluating genetic markers |
| US9524369B2 (en) | 2009-06-15 | 2016-12-20 | Complete Genomics, Inc. | Processing and analysis of complex nucleic acid sequence data |
| WO2011027966A2 (en) * | 2009-09-03 | 2011-03-10 | Seegene, Inc. | Td probe and its uses |
| EP2504448B1 (en) * | 2009-11-25 | 2016-10-19 | Bio-Rad Laboratories, Inc. | Methods and compositions for detecting genetic material |
| US8236574B2 (en) | 2010-03-01 | 2012-08-07 | Quanterix Corporation | Ultra-sensitive detection of molecules or particles using beads or other capture objects |
| WO2011109379A1 (en) | 2010-03-01 | 2011-09-09 | Quanterix Corporation | Methods and systems for extending dynamic range in assays for the detection of molecules or particles |
| EP2585593B1 (en) | 2010-06-24 | 2017-03-01 | Population Genetics Technologies Ltd. | Methods for polynucleotide library production, immortalization and region of interest extraction |
| US10669569B2 (en) | 2010-10-15 | 2020-06-02 | Navinci Diagnostics Ab | Dynamic range methods |
| CN101974638B (zh) * | 2010-11-10 | 2012-10-03 | 华东医学生物技术研究所 | 连接反应偶联核酸侵入反应与切刻内切酶反应的核酸信号扩增检测方法 |
| US9163281B2 (en) | 2010-12-23 | 2015-10-20 | Good Start Genetics, Inc. | Methods for maintaining the integrity and identification of a nucleic acid template in a multiplex sequencing reaction |
| US9952237B2 (en) | 2011-01-28 | 2018-04-24 | Quanterix Corporation | Systems, devices, and methods for ultra-sensitive detection of molecules or particles |
| EP2673380B1 (en) | 2011-02-09 | 2018-12-12 | Bio-Rad Laboratories, Inc. | Analysis of nucleic acids |
| US9556473B2 (en) | 2011-02-15 | 2017-01-31 | Leica Biosystems Newcastle Ltd | Methods for identifying nucleic acid sequences |
| EP2675916B1 (en) | 2011-02-15 | 2016-08-24 | Leica Biosystems Newcastle Limited | METHOD FOR LOCALIZED IN SITU DETECTION OF mRNA |
| US8759036B2 (en) | 2011-03-21 | 2014-06-24 | Affymetrix, Inc. | Methods for synthesizing pools of probes |
| US10597701B2 (en) | 2011-05-11 | 2020-03-24 | Navinci Diagnostics Ab | Unfolding proximity probes and methods for the use thereof |
| GB201107863D0 (en) | 2011-05-11 | 2011-06-22 | Olink Ab | Method and product |
| US9228233B2 (en) | 2011-10-17 | 2016-01-05 | Good Start Genetics, Inc. | Analysis methods |
| ES2741099T3 (es) | 2012-02-28 | 2020-02-10 | Agilent Technologies Inc | Método de fijación de una secuencia de recuento para una muestra de ácido nucleico |
| US8209130B1 (en) | 2012-04-04 | 2012-06-26 | Good Start Genetics, Inc. | Sequence assembly |
| US8812422B2 (en) | 2012-04-09 | 2014-08-19 | Good Start Genetics, Inc. | Variant database |
| US10227635B2 (en) | 2012-04-16 | 2019-03-12 | Molecular Loop Biosolutions, Llc | Capture reactions |
| KR101922124B1 (ko) | 2012-08-27 | 2018-11-26 | 삼성전자주식회사 | 시료 중 ｒｎａ로부터 ｄｎａ를 증폭하는 방법 |
| WO2014076214A1 (en) | 2012-11-14 | 2014-05-22 | Olink Ab | Rca reporter probes and their use in detecting nucleic acid molecules |
| EP2920324B1 (en) | 2012-11-14 | 2017-12-27 | Olink Bioscience AB | Localised rca-based amplification method |
| JP6112652B2 (ja) * | 2012-11-29 | 2017-04-12 | 国立大学法人広島大学 | 標的ｄｎａの特異的増幅方法 |
| ES2900102T3 (es) * | 2013-02-20 | 2022-03-15 | Univ Emory | Composiciones para la secuenciación de ácidos nucleicos en mezclas |
| JP6408552B2 (ja) | 2013-03-13 | 2018-10-17 | メソ スケール テクノロジーズ エルエルシー | 改善されたアッセイ方法 |
| US10114015B2 (en) | 2013-03-13 | 2018-10-30 | Meso Scale Technologies, Llc. | Assay methods |
| WO2014152421A1 (en) | 2013-03-14 | 2014-09-25 | Good Start Genetics, Inc. | Methods for analyzing nucleic acids |
| WO2014143623A1 (en) | 2013-03-15 | 2014-09-18 | The Lubrizol Corporation | Heavy metal free cpvc compositions |
| US8847799B1 (en) | 2013-06-03 | 2014-09-30 | Good Start Genetics, Inc. | Methods and systems for storing sequence read data |
| WO2015013681A1 (en) | 2013-07-25 | 2015-01-29 | Bio-Rad Laboratories, Inc. | Genetic assays |
| US9217167B2 (en) | 2013-07-26 | 2015-12-22 | General Electric Company | Ligase-assisted nucleic acid circularization and amplification |
| US9644232B2 (en) | 2013-07-26 | 2017-05-09 | General Electric Company | Method and device for collection and amplification of circulating nucleic acids |
| WO2015057565A1 (en) | 2013-10-18 | 2015-04-23 | Good Start Genetics, Inc. | Methods for assessing a genomic region of a subject |
| US10851414B2 (en) | 2013-10-18 | 2020-12-01 | Good Start Genetics, Inc. | Methods for determining carrier status |
| GB201320145D0 (en) | 2013-11-14 | 2014-01-01 | Olink Ab | Localised RCA-based amplification method using a padlock-probe |
| GB201321123D0 (en) | 2013-11-29 | 2014-01-15 | Linea Ab Q | Amplification of circular molecules |
| GB2520765A (en) | 2013-12-02 | 2015-06-03 | Vanadis Diagnostics Ab | Multiplex detection of nucleic acids |
| US10112194B2 (en) | 2014-04-14 | 2018-10-30 | Q-Linea Ab | Detection of microscopic objects |
| WO2015175530A1 (en) | 2014-05-12 | 2015-11-19 | Gore Athurva | Methods for detecting aneuploidy |
| CN112239774B (zh) | 2014-05-15 | 2024-12-03 | 中尺度技术有限责任公司 | 改进的测定方法 |
| EP3074539B1 (en) | 2014-06-13 | 2018-01-10 | Q-Linea AB | Method for detecting and characterising a microorganism |
| GB201413718D0 (en) | 2014-08-01 | 2014-09-17 | Olink Ab | Method for selecting a target nucleic acid sequence |
| GB201413717D0 (en) | 2014-08-01 | 2014-09-17 | Olink Ab | Method for selecting a target nucleic acid sequence |
| US20160048608A1 (en) | 2014-08-15 | 2016-02-18 | Good Start Genetics, Inc. | Systems and methods for genetic analysis |
| WO2016040446A1 (en) | 2014-09-10 | 2016-03-17 | Good Start Genetics, Inc. | Methods for selectively suppressing non-target sequences |
| US10429399B2 (en) | 2014-09-24 | 2019-10-01 | Good Start Genetics, Inc. | Process control for increased robustness of genetic assays |
| CA2965661C (en) | 2014-10-23 | 2023-09-26 | Ricardo Mancebo | Reagents and methods for isothermal chain reaction |
| EP4095261B1 (en) | 2015-01-06 | 2025-05-28 | Molecular Loop Biosciences, Inc. | Screening for structural variants |
| GB201507026D0 (en) | 2015-04-24 | 2015-06-10 | Linea Ab Q | Medical sample transportation container |
| EP4219532A3 (en) | 2015-06-05 | 2023-08-16 | Dana-Farber Cancer Institute, Inc. | Compositions and methods for transient gene therapy with enhanced stability |
| US10344336B2 (en) | 2015-06-09 | 2019-07-09 | Life Technologies Corporation | Methods, systems, compositions, kits, apparatus and computer-readable media for molecular tagging |
| GB201511129D0 (en) | 2015-06-24 | 2015-08-05 | Linea Ab Q | Method of determining antimicrobial susceptibility of a microorganism |
| EP3608420B1 (en) | 2015-07-29 | 2021-05-19 | Progenity, Inc. | Nucleic acids and methods for detecting chromosomal abnormalities |
| GB201518655D0 (en) | 2015-10-21 | 2015-12-02 | Olink Ab | Method for generating proximity probes |
| CN108779487A (zh) | 2015-11-16 | 2018-11-09 | 普罗格尼迪公司 | 用于检测甲基化状态的核酸和方法 |
| US10718017B2 (en) * | 2016-03-31 | 2020-07-21 | Arizona Board Of Regents On Behalf Of Arizona State University | Probes and methods for measuring tandem repeats |
| GB2554767A (en) | 2016-04-21 | 2018-04-11 | Q Linea Ab | Detecting and characterising a microorganism |
| US10655170B2 (en) | 2016-07-06 | 2020-05-19 | Takara Bio Usa, Inc. | Coupling adaptors to a target nucleic acid |
| GB201614023D0 (en) | 2016-08-16 | 2016-09-28 | Olink Bioscience Ab | Double-stranded circle probes |
| GB201621514D0 (en) | 2016-12-16 | 2017-02-01 | Q-Linea Ab | Padlock probe detection method |
| US11661624B2 (en) | 2017-03-30 | 2023-05-30 | Pioneer Hi-Bred International, Inc. | Methods of identifying and characterizing gene editing variations in nucleic acids |
| US11753434B2 (en) | 2017-04-14 | 2023-09-12 | Dana-Farber Cancer Institute, Inc. | Compositions and methods for transient gene therapy with enhanced stability |
| US11459603B2 (en) * | 2017-05-23 | 2022-10-04 | Rutgers, The State University Of New Jersey | Target mediated in situ signal amplification with dual interacting hairpin probes |
| CN111315895A (zh) | 2017-09-14 | 2020-06-19 | 豪夫迈·罗氏有限公司 | 用于产生环状单链dna文库的新型方法 |
| EP3682027B1 (en) | 2017-09-15 | 2025-02-26 | F. Hoffmann-La Roche AG | Hybridization-extension-ligation strategy for generating circular single-stranded dna libraries |
| ES3029737T3 (en) | 2017-10-06 | 2025-06-25 | 10X Genomics Inc | Rna templated ligation |
| WO2019068797A1 (en) | 2017-10-06 | 2019-04-11 | F. Hoffmann-La Roche Ag | CIRCULARIZATION METHODS FOR THE PREPARATION OF SAMPLE SAMPLES OF UNIQUE MOLECULES |
| WO2019086531A1 (en) | 2017-11-03 | 2019-05-09 | F. Hoffmann-La Roche Ag | Linear consensus sequencing |
| JP7096893B2 (ja) | 2018-02-05 | 2022-07-06 | エフ．ホフマン－ラ ロシュ アーゲー | 単一分子のための一本鎖環状ｄｎａ鋳型の作製 |
| CN111936635B (zh) | 2018-03-02 | 2024-08-23 | 豪夫迈·罗氏有限公司 | 用于单分子测序的单链环状dna模板的产生 |
| WO2019195346A1 (en) | 2018-04-02 | 2019-10-10 | Progenity, Inc. | Methods, systems, and compositions for counting nucleic acid molecules |
| CN109444102B (zh) * | 2018-12-18 | 2021-03-23 | 济南大学 | 一种检测赭曲霉毒素a的荧光生物传感器及其制备方法和应用 |
| KR20220010471A (ko) | 2019-03-01 | 2022-01-25 | 메소 스케일 테크놀러지즈, 엘엘시 | 면역검정 방법에서 사용을 위한 전기화학발광성 표지화된 프로브, 이의 사용 방법 및 이를 포함하는 키트 |
| WO2020206170A1 (en) | 2019-04-02 | 2020-10-08 | Progenity, Inc. | Methods, systems, and compositions for counting nucleic acid molecules |
| JP7727628B2 (ja) | 2019-12-03 | 2025-08-21 | アラマー バイオサイエンシーズ， インク． | 核酸結合免疫サンドイッチアッセイ（ｎｕｌｉｓａ） |
| GB201919032D0 (en) | 2019-12-20 | 2020-02-05 | Cartana Ab | Method of detecting an analyte |
| GB201919029D0 (en) | 2019-12-20 | 2020-02-05 | Cartana Ab | Method of detecting an analyte |
| US11492662B2 (en) | 2020-08-06 | 2022-11-08 | Singular Genomics Systems, Inc. | Methods for in situ transcriptomics and proteomics |
| EP4121557A4 (en) | 2020-08-06 | 2024-05-01 | Singular Genomics Systems, Inc. | Spatial sequencing |
| WO2022056078A1 (en) * | 2020-09-11 | 2022-03-17 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Rnase h-assisted detection assay for rna (radar) |
| AU2021345359A1 (en) | 2020-09-21 | 2023-05-11 | Enumera Molecular, Inc. | Compositions and methods for isolation of cell-free dna |
| US12497651B2 (en) | 2020-11-23 | 2025-12-16 | Pleno, Inc. | Encoded dual-probe endonuclease assays |
| WO2022235764A1 (en) | 2021-05-05 | 2022-11-10 | Singular Genomics Systems, Inc. | Multiomic analysis device and methods of use thereof |
| GB202203185D0 (en) | 2022-03-08 | 2022-04-20 | Rarity Bioscience Ab | Method for detecting nucleic acid amplification products |
| WO2024249961A1 (en) | 2023-06-01 | 2024-12-05 | Singular Genomics Systems, Inc. | Methods and probes for detecting polynucleotide sequences in cells and tissues |
| GB202310278D0 (en) | 2023-07-05 | 2023-08-16 | Navinci Diagnostics Ab | Stabilisation of phi29 polymerase |
| CN120249442B (zh) * | 2025-06-04 | 2025-09-26 | 北京航空航天大学杭州创新研究院 | 一种基于邻近核酸扩增信号放大的超灵敏免疫检测方法 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5011769A (en) | 1985-12-05 | 1991-04-30 | Meiogenics U.S. Limited Partnership | Methods for detecting nucleic acid sequences |
| US5403711A (en) | 1987-11-30 | 1995-04-04 | University Of Iowa Research Foundation | Nucleic acid hybridization and amplification method for detection of specific sequences in which a complementary labeled nucleic acid probe is cleaved |
| AU649066B2 (en) * | 1990-07-25 | 1994-05-12 | Syngene, Inc. | Circular extension for generating multiple nucleic acid complements |
| JP3085409B2 (ja) | 1991-03-29 | 2000-09-11 | 東洋紡績株式会社 | 標的核酸配列の検出方法およびそのための試薬キット |
| US6077668A (en) * | 1993-04-15 | 2000-06-20 | University Of Rochester | Highly sensitive multimeric nucleic acid probes |
| US5714320A (en) | 1993-04-15 | 1998-02-03 | University Of Rochester | Rolling circle synthesis of oligonucleotides and amplification of select randomized circular oligonucleotides |
| WO1995014106A2 (en) | 1993-11-17 | 1995-05-26 | Id Biomedical Corporation | Cycling probe cleavage detection of nucleic acid sequences |
| DE69528670T2 (de) | 1994-12-23 | 2004-03-11 | Dade Behring Inc., Deerfield | Nachweis von nukleinsäuren durch nuklease-katalysierte produktbildung |
| SE504798C2 (sv) | 1995-06-16 | 1997-04-28 | Ulf Landegren | Immunanalys och testkit med två reagens som kan tvärbindas om de adsorberats till analyten |
| US6143495A (en) | 1995-11-21 | 2000-11-07 | Yale University | Unimolecular segment amplification and sequencing |
| US5854033A (en) * | 1995-11-21 | 1998-12-29 | Yale University | Rolling circle replication reporter systems |
| WO1997020948A1 (en) | 1995-12-05 | 1997-06-12 | Koch Joern Erland | A cascade nucleic acid amplification reaction |
| US6124120A (en) | 1997-10-08 | 2000-09-26 | Yale University | Multiple displacement amplification |
| EP1066414B1 (en) | 1998-03-25 | 2009-06-10 | Olink AB | Rolling circle replication of padlock probes |
| US6037130A (en) * | 1998-07-28 | 2000-03-14 | The Public Health Institute Of The City Of New York, Inc. | Wavelength-shifting probes and primers and their use in assays and kits |
| US6150112A (en) | 1998-09-18 | 2000-11-21 | Yale University | Methods for identifying DNA sequences for use in comparison of DNA samples by their lack of polymorphism using Y shape adaptors |
| US6235502B1 (en) * | 1998-09-18 | 2001-05-22 | Molecular Staging Inc. | Methods for selectively isolating DNA using rolling circle amplification |
| US6830884B1 (en) * | 1998-12-15 | 2004-12-14 | Molecular Staging Inc. | Method of amplification |
| AU781962B2 (en) | 1998-12-15 | 2005-06-23 | Qiagen Gmbh | A method of amplification of a circularised nucleic acid probe |
| US6274320B1 (en) * | 1999-09-16 | 2001-08-14 | Curagen Corporation | Method of sequencing a nucleic acid |
| WO2001038580A2 (en) | 1999-11-26 | 2001-05-31 | Curagen Corporation | Nucleic acid probe arrays |
| JP2003532380A (ja) | 1999-12-02 | 2003-11-05 | モレキュラー ステージング，インコーポレイテッド | 線状自己アニーリングセグメントからの一本鎖環状ｄｎａの産出 |
| US6221603B1 (en) * | 2000-02-04 | 2001-04-24 | Molecular Dynamics, Inc. | Rolling circle amplification assay for nucleic acid analysis |
| US6291187B1 (en) * | 2000-05-12 | 2001-09-18 | Molecular Staging, Inc. | Poly-primed amplification of nucleic acid sequences |
| US6350580B1 (en) * | 2000-10-11 | 2002-02-26 | Stratagene | Methods for detection of a target nucleic acid using a probe comprising secondary structure |
| US6573051B2 (en) * | 2001-03-09 | 2003-06-03 | Molecular Staging, Inc. | Open circle probes with intramolecular stem structures |
| GB2378245A (en) * | 2001-08-03 | 2003-02-05 | Mats Nilsson | Nucleic acid amplification method |
| SE0401270D0 (sv) | 2004-05-18 | 2004-05-18 | Fredrik Dahl | Method for amplifying specific nucleic acids in parallel |
-
2001
- 2001-08-03 GB GB0118959A patent/GB2378245A/en not_active Withdrawn
-
2002
- 2002-07-12 EP EP02741612.2A patent/EP1423532B1/en not_active Expired - Lifetime
- 2002-07-12 EP EP10003679.7A patent/EP2236622B1/en not_active Expired - Lifetime
- 2002-07-12 WO PCT/SE2002/001378 patent/WO2003012119A2/en not_active Ceased
- 2002-07-12 JP JP2003517293A patent/JP2004536617A/ja active Pending
- 2002-07-12 EP EP10003586.4A patent/EP2251439B1/en not_active Expired - Lifetime
- 2002-07-12 US US10/483,900 patent/US7320860B2/en not_active Expired - Lifetime
- 2002-07-12 AU AU2002314693A patent/AU2002314693A1/en not_active Abandoned
- 2002-07-12 EP EP10003678A patent/EP2224016A1/en not_active Withdrawn
- 2002-07-12 CA CA002455803A patent/CA2455803A1/en not_active Abandoned
-
2007
- 2007-11-28 US US11/946,706 patent/US7790388B2/en not_active Ceased
-
2008
- 2008-12-12 JP JP2008316989A patent/JP4559517B2/ja not_active Expired - Lifetime
-
2009
- 2009-10-02 JP JP2009230088A patent/JP4675424B2/ja not_active Expired - Lifetime
-
2010
- 2010-06-01 JP JP2010125694A patent/JP5313204B2/ja not_active Expired - Lifetime
-
2011
- 2011-12-19 US US13/329,998 patent/USRE44265E1/en not_active Expired - Lifetime
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009077735A (ja) * | 2001-08-03 | 2009-04-16 | Biocyclica Ab | 核酸増幅方法 |
| JP2008522628A (ja) * | 2004-12-11 | 2008-07-03 | サイトジェニックス， インコーポレイテッド | 高品質核酸のセルフリー生合成及びその使用 |
| JP2011505161A (ja) * | 2007-12-04 | 2011-02-24 | ピエール、ファーブル、メディカマン | 抗体ライブラリーを作製およびスクリーニングするための新規な方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1423532A2 (en) | 2004-06-02 |
| US7790388B2 (en) | 2010-09-07 |
| JP2009077735A (ja) | 2009-04-16 |
| EP2236622B1 (en) | 2017-09-06 |
| US20050287526A1 (en) | 2005-12-29 |
| GB0118959D0 (en) | 2001-09-26 |
| WO2003012119A2 (en) | 2003-02-13 |
| JP5313204B2 (ja) | 2013-10-09 |
| EP2224016A1 (en) | 2010-09-01 |
| CA2455803A1 (en) | 2003-02-13 |
| GB2378245A (en) | 2003-02-05 |
| EP1423532B1 (en) | 2013-05-22 |
| WO2003012119A3 (en) | 2003-11-13 |
| EP2236622A3 (en) | 2010-11-03 |
| USRE44265E1 (en) | 2013-06-04 |
| JP4675424B2 (ja) | 2011-04-20 |
| US7320860B2 (en) | 2008-01-22 |
| JP2009297045A (ja) | 2009-12-24 |
| AU2002314693A1 (en) | 2003-02-17 |
| JP2010183916A (ja) | 2010-08-26 |
| EP2251439B1 (en) | 2013-09-11 |
| EP2236622A2 (en) | 2010-10-06 |
| JP4559517B2 (ja) | 2010-10-06 |
| US20080131899A1 (en) | 2008-06-05 |
| EP2251439A1 (en) | 2010-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4559517B2 (ja) | 核酸増幅方法 | |
| US20250263779A1 (en) | Methods of detecting an analyte | |
| JP6571895B1 (ja) | 核酸プローブ及びゲノム断片検出方法 | |
| AU2010290277B2 (en) | TD probe and its uses | |
| EP2516679B1 (en) | Tsg primer target detection | |
| CA2979858C (en) | Detection of target nucleic acid sequences by pto cleavage and extension assay in a liquid phase | |
| CA2790153C (en) | Thd primer target detection | |
| JPH02268683A (ja) | 単一プライマーを用いる核酸の増幅 | |
| JP3909010B2 (ja) | 高度ダイナミックレンジを有する定量的多重ｐｃｒ | |
| KR102672338B1 (ko) | 분할된 t7 프로모터를 이용한 중증 급성 호흡기 증후군 코로나바이러스 2 검출 및/또는 이의 돌연변이 검출용 등온 단일 반응 프로브 세트 및 이의 용도 | |
| HK1245352A1 (en) | Method for the simultaneous detection of multiple nucleic acid sequences in a sample |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050530 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080613 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20080912 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080922 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20081014 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20081021 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20081112 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20081119 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20081128 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20081128 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090106 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090403 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090410 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090424 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20090522 |